About Tissue Biomarker Quantification
Tissue Biomarker Quantification covers the analytical layer that turns stained whole slide images into per-cell measurements: marker positivity, co-expression patterns, spatial neighbourhoods, and microenvironment composition. Translational researchers, pathologists supporting clinical trials, and biomarker scientists in pharma and diagnostics rely on these tools to replace manual scoring with reproducible readouts tied to tissue context. The operational constraints are unusual for the parent category — gigapixel image sizes, antibody panel variability, scanner and stain heterogeneity, and the need to keep cell-level outputs auditable when they feed companion diagnostic claims or trial endpoints.
Two signals stand out in the directory. First, almost every entry is AI/ML-driven and structured as an analytical platform rather than a standalone engine, reflecting how tightly model inference is now coupled to case management, annotation, and review. Second, deployment leans heavily cloud or hybrid, with on-premise representing a small share — a notable choice given that pharma, biotech, and clinical or diagnostic users dominate the user base. Compliance coverage clusters around EU MDR and ISO 13485, consistent with the category's drift toward regulated diagnostic and trial use rather than purely exploratory research.
Browse Tissue Biomarker Analysis Software
AI-driven PD-L1 scoring for lung cancer pathology, delivering standardized tumor proportion assessment and reducing reporting time by up to 46%.
AI-powered quantification of breast cancer biomarkers HER2, ER, PR, and Ki67, including detection of HER2 low and ultralow expression.
Multi-organ tissue quantification from a single non-contrast MRI scan, generating 49 metrics to support clinical decision-making.
AI-powered clinical workflow and patient data management for ophthalmology, with OCT analysis, retinal layer segmentation, and tele-ophthalmology capabilities.
Quantitative small bowel motility assessment from cine MRI for objective Crohn's disease activity monitoring and treatment response tracking.
HALO Macrodissection Solutions
AI-powered tumor quantification and ROI selection for macrodissection workflows across lung, colorectal, and breast cancer specimens.
Single-cell analysis for IHC/HC stained tissue sections, TMAs, and cell preparations with spectral unmixing and contextual ROI-based measurements.
AI-powered histopathology analysis quantifying inflammatory microenvironment from H&E whole slide images for IBD research.
AI-powered H&E and IHC analysis for breast pathology, automating detection of malignant and benign findings with objective scoring for HER2, ER/PR, and Ki67.
AI-powered quantification of immunohistochemistry biomarkers at single-cell resolution for cancer drug development and patient stratification.
Common Questions About Tissue Biomarker Quantification
Companies with the largest Tissue Biomarker Analysis software portfolios
Mindpeak
- AI-powered image analysis for clinical pathology diagnosis, biomarker detection, and precision medicine.
Lunit
- AI-powered cancer detection and precision oncology across screening, diagnosis, and biomarker development.
PathAI
- AI-powered pathology for drug development, clinical trials, and diagnostic workflows across biopharma and anatomic pathology laboratories.